Business Segments · Other Segment items
Business Segments — Other Segment items
Vertex Pharmaceuticals Business Segments — Other Segment items decreased by 71.4% to $200K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.0%, from $19.8M to $200K. Over 3 years (FY 2022 to FY 2025), Business Segments — Other Segment items shows a downward trend with a -47.8% CAGR.
Analysis
StatementSegment
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
How to read this metric
High volatility or large values may indicate non-recurring events that distort core operational performance.
Detailed definition
Miscellaneous income or expenses that do not fit into core operating categories like R&D or SG&A. This may include legal...
Peer comparison
Often labeled as 'Other Income/Expense' or 'Non-recurring items' by peers.
Metric ID:
vrtx_segment_pharmaceuticals_other_segment_itemsHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.53M | $40.53M | $40.53M | $40.53M | $3.83M | $3.83M | $3.83M | $3.83M | $41.5M | $33.5M | $24.7M | $16.5M | $19.8M | -$8.6M | $11.2M | $700K | $200K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -90.6% | +0.0% | +0.0% | +0.0% | +985.0% | -19.3% | -26.3% | -33.2% | +20.0% | -143.4% | +230.2% | -93.8% | -71.4% |
| YoY Change | — | — | — | — | -90.6% | -90.6% | -90.6% | -90.6% | +985.0% | +775.8% | +545.8% | +331.4% | -52.3% | -125.7% | -54.7% | -95.8% | -99.0% |
Range-$8.6M – $41.5M
CAGR-73.5%
Avg YoY Growth+142.2%
Median YoY Growth-90.6%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's business segments — other segment items?
- Vertex Pharmaceuticals (VRTX) reported business segments — other segment items of $200K in Q1 2026.
- How has Vertex Pharmaceuticals's business segments — other segment items changed year-over-year?
- Vertex Pharmaceuticals's business segments — other segment items decreased by 99.0% year-over-year, from $19.8M to $200K.
- What is the long-term trend for Vertex Pharmaceuticals's business segments — other segment items?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's business segments — other segment items has grown at a -47.8% compound annual growth rate (CAGR), from $162.1M to $23.1M.
- What does business segments — other segment items mean?
- Unusual or non-core income and expenses that don't fit into standard operating categories.